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ASTRIC CANCER IS THE FOURTH most common type of cancer and the second most common among cancer deaths worldwide. 1 While tumors of the cardia, the upper part of the stomach adjoining the esophagus, may be related to gastroesophageal reflux, the majority of noncardia gastric cancers are attributable to chronic mucosal infection by the bacterium Helicobacter pylori. 2 The presumed mechanism of carcinogenesis is the induction of inflammation and consequent gastritis, the initial lesions in a multistage process. 3 In both high-and low-prevalence populations, H pylori infection is commonly acquired in childhood and generally not later. In the United States, prevalence of infection increases with age, reflecting improvements in hygienic conditions and decreased crowding during childhood for younger generations. 4 Prevalence also varies by race, socioeconomic status, and geographic region, 5 contributing to population differences in gastric cancer risk. 6 Apart from H pylori infection, nutritional exposures are implicated as risk factors for noncardia gastric cancer. Consumption of salt and salt-preserved foods is associated with increased incidence, whereas consumption of fresh fruits and vegetables is protective. 7 Thus, modern practices of food preservation and refrigeration have favorably influenced components of diet associated with gastric cancer risk. Overall, gastric cancer incidence has steadily declined in many countries over the past 50 years or longer. However, overall trends may mask important agespecific differences. 8 Furthermore, the overall decline runs counter to the subsite-specific rise in cardia cancers that may be related to obesity and gastroesophageal reflux. 9 We therefore analyzed US population-based agespecific data for noncardia gastric cancer. 10 The SEER registries databases cover up to 26% of the US population. Diagnoses are validated by microscopic confirmation and case ascertainment is greater than 96% for cancers diagnosed or treated in hospitals in the geographic areas SEER covers. 11 Our research did not involve interaction with human subjects or use of personal identifying information from these publicly available SEER data, so institutional review board approval and informed consent were not applicable.
METHODS
We Annual incidence rates were agestandardized to the 2000 US population by the direct method. Temporal trends in the age-standardized rates were quantified by the estimated annual percentage change (EAPC) using least squares linear regression. 13 We used the age-period-cohort framework to account for effects that might vary over the interrelated time scales of chronologic age, calendar period of diagnosis, and year of birth. Age patterns reflect in part the biological determinants of disease between younger and older persons; calendar period effects reflect secular trends that may affect all ages simultaneously (eg, changing diagnostic or screening practices); and birth cohort effects reflect risk factor exposures that may vary from one generation to the next.
To facilitate age-period-cohort analysis, we used equally spaced 5-year calendar periods and age groups.
14 There were six 5-year calendar periods (1977) (1978) (1979) (1980) (1981) (1982) (1983) (1984) (1985) (1986) (1897, 1902, . . . , 1977, referred to by mid year of birth). To increase statistical precision for tabular presentation, the twelve 5-year age groups were further collapsed into 25 to 39 years, 40 to 59 years, and 60 to 84 years.
Age-period-cohort models were used to obtain smoothed ("denoised"), fitted age-specific incidence rates, 15 to calculate long-term log-linear trends due to period and cohort effects ("net drift"), 16, 17 and to quantify deviations from log-linear trends associated with calendar period and birth cohort, 18 as previously described. 19 We assessed significant period and cohort deviations using a "moving window" that contrasted the 3 intervals preceding a given targeted year (calendar period or birth cohort) with the 3 intervals subsequent to that year. 20 Generalized linear regression models were used to test whether time trends varied for the 9 subgroups defined by race (white, black, and other) and age (25-39, 40-59, and 60-84 years). The complete model included main effects for combinations of race and age, the linear trend for calendar time, and terms for their interaction. We compared the fit of this model with the fit of a model without interaction terms to obtain a likelihood ratio test.
Statistical analyses were performed in Matlab, version R2009b (MathWorks Inc, Natick, Massachusetts). Based on the expected declines for noncardia gastric carcinoma among whites aged 60 to 84 years, there was a sufficient number of observed cases in whites aged 25 to 39 years to detect as alternatives a stable incidence trend with 91% power and a 1%-per-year increasing trend with greater than 99% power. All statistical tests were 2-sided and assessed for statistical significance at PϽ .05.
RESULTS
In 718 677 778 person-years of observation, the SEER 9, 13, and 17 registries identified 83 225 total cases of gastric cancer diagnosed at ages 25 In all 3 race groups, the overall agestandardized incidence rates of noncardia gastric cancer per 100 000 person-years for ages 25 to 84 years declined significantly over time: among whites, from 5. Notwithstanding these overall trends, there was striking variation among age and race groups (PϽ.001 for ageϫrace interaction). Among white men, agespecific rates increased for each age group younger than 40 years but dec r e a s e d f o r o l d e r a g e g r o u p s (FIGURE 1A) . Among white women, the pattern was similar, with age-specific rates increasing for each age group younger than 50 years ( Figure 1B 8 (95% CI, 12.5-13.1) for ages 60 to 84 years. However, age-specific rates decreased for all 5-year age groups among blacks (FIGURE 2A ) and all except the youngest age group among other races ( Figure 2B ). The corresponding EAPCs for persons aged 25 to 39 years were ϩ2.7% per year among whites, −1.7% per year among blacks, and −1.5% per year among other races (Table 2) .
For successive birth cohorts of whites, age-specific incidence of noncardia gastric cancer decreased through the 1947 cohort, then progressively increased for the 1952 and subsequent cohorts. Specifically, incidence declined by 1.6% per year over the 1932 to 1942 cohorts then increased by 2.2% per year over the 1952 to 1962 cohorts. The difference between these slopes before and after the 1947 mid year of birth was 
07).
There were no appreciable calendar period deviations from linear trends among any of the 3 race groups. When stratified by county-level socioeconomic status, the patterns of increasing rates in younger whites and decreasing rates in older whites were similar for counties with less than 10% and 10% to 19.9% population below the poverty level; there were too few cases among whites in counties with 20% poverty or more to assess age-specific temporal trends. For all 3 strata, rates for younger individuals decreased or were stable among blacks and other races.
In contrast with noncardia gastric cancer, incidence of cardia cancer was relatively stable during the study period for all race and age groups. Overall age-standardized incidence per 100 000 changed from 2.4 (95% CI, 2.3-2.5) in 1977-1981 to 2.9 (95% CI, 2.9-3.0) in 2001-2006 among whites, from 1.6 (95% CI, 1.2-2.0) to 1.9 (95% CI, 1.7-2.1) among blacks, and from 2.1 (95% CI, 1.6-2.7) to 2.0 (95% CI, 1.8-2.2) among other races. Corresponding EAPCs were 0.4% per year (95% CI, 0.02%-0.7%) for whites, 0% per year (95% CI, −0.8% to 0.8%) for blacks, and −0.7% per year (95% CI, −1.5% to 0.11%) for other races. Among the 9 subgroups of race (white, black, and other) and age (25-39, 40-59, and 60-84 years), rates per 100 000 changed significantly only for whites aged 60 to 84 years, from 7.4 (95% CI, 6.9-7.9) to 9.9 (95% CI, 9.6-10.2), with a corresponding EAPC of 0.4% per year (95% CI, 0.02%-0.7%). Furthermore, there were no significant cohort changes for any target year of birth among whites, blacks, or other races.
COMMENT
Our analysis revealed divergent trends in US noncardia gastric cancer incidence rates by age. Among whites, rates are declining in older adults but unexpectedly increasing in persons born . This variation contrasts with temporal trends for cardia cancer, which varied little in our race and age groups during the study period. Diagnostic and/or nosologic practice patterns for gastric cancer could potentially affect trends for anatomical subsites. In particular, reclassification of unspecified cases could lead to an apparent increase in noncardia gastric cancer; however, such reclassification would need to be differential by age to account for an increase restricted to younger individuals. Indeed, while the percentage of gastric cancer cases with unspecified subsites decreased during the study period, decreases were similar in whites aged 60 to 84 years (decreasing from 27% in 1977-1981 to 17% in [2002] [2003] [2004] [2005] [2006] and whites aged 25 to 39 years (decreasing from 29% to 23%, respectively).
Declining noncardia gastric cancer rates in older adults may reflect cohortspecific decreases in H pylori acquisition during childhood as well as favorable changes in diet; however, the reasons for discrepant trends in younger adults are unclear. Given the established role of H pylori exposure in the development of noncardia gastric adenocarcinoma, changes in H pylori infection patterns following the 1952 birth cohort may have contributed to the increasing incidence rates among younger persons. Hypothetically, the long-term decline in the prevalence of H pylori could have reversed or the age at infection could have changed, since early-life infection has been linked to cancer risk. 21 It is also possible that cancers in younger adults may point to the emergence of a new carcinogenic process, perhaps unmasked by the eradication of H pylori in gastric mucosa.
22
Because Epstein-Barr virus has been linked to a subset of gastric cancer, 23 it seems possible that this or other agents may play a greater role as the gastric microbial flora has changed.
Another potential explanation is the role of diet, notably salt intake, which has been increasing among all age groups in the United States. 24 Obesity has been linked to the increasing incidence of cardia cancer, but it has not been found to be a risk factor for noncardia tumors as a group. 25 Tobacco smoking is a risk factor for both cardia and noncardia gastric cancer, 26 but tobacco use is slowly but steadily declining among adults, including young adults. 
1977-1981
The possible role of long-term gastric acid inhibitory therapy as a potential cancer initiator should also be considered. 27 Histamine 2 receptor blockers were in widespread use at the beginning of our study period, supplanted by the more potent proton-pump inhibitors starting in September 1989. 28 However, this hypothesis seems unlikely to explain an increase in rates restricted to younger cohorts.
Gastric cancer risk is substantially greater for Hispanic than nonHispanic whites. 29 However, SEER did not provide population estimates for these subgroups until 1992, so we were unable to distinguish ethnicityspecific rates for the entire study period. Nevertheless, in a sensitivity analysis for the period 1992-2006 among non-Hispanic whites, we observed similar age-specific trends as seen for the entire study period 1977-2006 among whites overall. Specifically, the slope differences before and after the 1947 mid year of birth did not substantially change and remained statistically significant despite the smaller number of cases and shorter time frame (3.4% per year; 95% CI, 0.6%-6.1%; P=.02). Thus, the age-specific differences among whites overall for the entire study period 1977-2006 cannot be fully explained by immigration of Hispanics into the SEER catchment areas.
Finally, this study has the usual caveats of descriptive epidemiology, such as missing data, lack of individuallevel information, and nonstandardized histopathological review. We were also unable to examine trends by individual subsite of noncardia tumors or for the Lauren classifications of intestinal and diffuse histologic subtypes because of incomplete reporting and small numbers. However, the SEER database covered 17 regional populationbased tumor registries with meticulous data collection and standards. Targeting all cancer cases in residents of defined geographic areas, the largescale SEER database is broadly representative of cancer incidence in the United States as a whole. Further agespecific analyses of noncardia gastric cancer incidence trends for low-risk populations will be informative.
